Cyrus Biotechnology Raises $8M Series A Led by Trinity Ventures to Expand Cloud-Based Protein Modeling for Drug Discovery
Cyrus Biotechnology secured $8 million in Series A funding led by Trinity Ventures to advance its cloud-based protein modeling platform, Cyrus Bench, which aids drug discovery. The software builds on the University of Washington's Rosetta platform, enabling researchers to design novel protein configurations for therapeutic applications.